Smartleaf Asset Management
FLNA icon

Smartleaf Asset Management’s Filana Therapeutics FLNA Stock Holding History

Smartleaf Asset Management’s Portfolio FLNA Stock Details FLNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$1.27K Hold
1,369
– – ﹤0.01% 3141
2026
Q2 		$1.67K Hold
1,369
– – ﹤0.01% 2992
2026
Q1 		$2.22K Hold
1,369
– – ﹤0.01% 2936
2025
Q4 		$2.78K Buy
+1,369
New +$4.38K ﹤0.01% 2883

Other funds holding FLNA

Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $114B AUM 35.47% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Squarepoint
Squarepoint New York $90.8B AUM 26.98% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $85.7B AUM 51.02% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $463B AUM
Renaissance Technologies
Renaissance Technologies New York $73.4B AUM 32.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $121B AUM 21.47% 1-Year Est. Return

Smartleaf Asset Management's FLNA Position: Q3 2026 in Review

Smartleaf Asset Management held its Filana Therapeutics (FLNA) position steady in Q3 2026 at 1,369 shares worth $1.27K. The position accounts for ﹤0.01% of the portfolio, ranked #3141.

Smartleaf Asset Management first reported a position in FLNA in Q4 2025 and has held it in 4 quarters since. The position peaked at $2.78K in Q4 2025. 60 funds tracked by Wall St. Rank hold FLNA as of Q3 2026.

  • Smartleaf Asset Management held 1,369 shares of Filana Therapeutics worth $1.27K as of Q3 2026.
  • Smartleaf Asset Management left its Filana Therapeutics share count unchanged in Q3 2026.
  • Filana Therapeutics made up ﹤0.01% of Smartleaf Asset Management's portfolio in Q3 2026, its #3141 holding.
  • Smartleaf Asset Management first reported a position in Filana Therapeutics in Q4 2025 and has held it in 4 quarters since.
  • Smartleaf Asset Management's Filana Therapeutics position peaked at $2.78K in Q4 2025.
  • 60 funds tracked by Wall St. Rank held Filana Therapeutics as of Q3 2026.

Based on Smartleaf Asset Management's 13F filing for Q3 2026, filed 10 Nov 2026.